Arkolith/Insider Trading/COLL/Form 4

Bohlin Garen G

DirectorCOLLEGIUM PHARMACEUTICAL, INC (COLL) · full profile →Form 4 · filed May 13, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$323K
Net Open-Market Flow
-$323K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 11, 2026Option exercise(M)9K$16.49$143K71K
May 11, 2026Sell(S)9K$37.18$323K62K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 11, 2026Option exercise(M)9K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001254705-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML